JP2022526841A5 - - Google Patents

Info

Publication number
JP2022526841A5
JP2022526841A5 JP2021559971A JP2021559971A JP2022526841A5 JP 2022526841 A5 JP2022526841 A5 JP 2022526841A5 JP 2021559971 A JP2021559971 A JP 2021559971A JP 2021559971 A JP2021559971 A JP 2021559971A JP 2022526841 A5 JP2022526841 A5 JP 2022526841A5
Authority
JP
Japan
Prior art keywords
seq
chain variable
variable region
polypeptide sequence
heavy chain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021559971A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022526841A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/027092 external-priority patent/WO2020210247A1/en
Publication of JP2022526841A publication Critical patent/JP2022526841A/ja
Publication of JP2022526841A5 publication Critical patent/JP2022526841A5/ja
Pending legal-status Critical Current

Links

JP2021559971A 2019-04-12 2020-04-07 ヒト化抗葉酸受容体1キメラ抗原受容体及びその使用 Pending JP2022526841A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201962832975P 2019-04-12 2019-04-12
US62/832,975 2019-04-12
US201962863330P 2019-06-19 2019-06-19
US62/863,330 2019-06-19
US201962931988P 2019-11-07 2019-11-07
US62/931,988 2019-11-07
PCT/US2020/027092 WO2020210247A1 (en) 2019-04-12 2020-04-07 Humanized anti-folate receptor 1 chimeric antigen receptors and uses thereof

Publications (2)

Publication Number Publication Date
JP2022526841A JP2022526841A (ja) 2022-05-26
JP2022526841A5 true JP2022526841A5 (cg-RX-API-DMAC7.html) 2022-06-29

Family

ID=72751784

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021559971A Pending JP2022526841A (ja) 2019-04-12 2020-04-07 ヒト化抗葉酸受容体1キメラ抗原受容体及びその使用

Country Status (12)

Country Link
US (1) US20220162301A1 (cg-RX-API-DMAC7.html)
EP (1) EP3953392A1 (cg-RX-API-DMAC7.html)
JP (1) JP2022526841A (cg-RX-API-DMAC7.html)
KR (1) KR20210151173A (cg-RX-API-DMAC7.html)
CN (1) CN113728007B (cg-RX-API-DMAC7.html)
AU (1) AU2020272672A1 (cg-RX-API-DMAC7.html)
BR (1) BR112021017046A2 (cg-RX-API-DMAC7.html)
CA (1) CA3132204A1 (cg-RX-API-DMAC7.html)
IL (1) IL287156A (cg-RX-API-DMAC7.html)
MX (1) MX2021012488A (cg-RX-API-DMAC7.html)
SG (1) SG11202109051PA (cg-RX-API-DMAC7.html)
WO (1) WO2020210247A1 (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL303269A (en) 2020-12-03 2023-07-01 Century Therapeutics Inc Genetically engineered cells and uses thereof
US11661459B2 (en) 2020-12-03 2023-05-30 Century Therapeutics, Inc. Artificial cell death polypeptide for chimeric antigen receptor and uses thereof
TW202241935A (zh) 2020-12-18 2022-11-01 美商世紀治療股份有限公司 具有可調適受體專一性之嵌合抗原受體系統
EP4771044A1 (en) * 2023-09-01 2026-07-08 Institute for Environmental Health, Inc. Variably deamidated gluten polypeptides and antibodies against same
WO2025087935A1 (en) * 2023-10-26 2025-05-01 Miltenyi Biotec B.V. & Co. KG Chimeric antigen receptor specific for folate receptor 1
CN120005830A (zh) * 2023-11-06 2025-05-16 复星凯瑞(上海)生物科技有限公司 一种分泌cd47-pd-l1的基因修饰的免疫细胞的制备及应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040142325A1 (en) * 2001-09-14 2004-07-22 Liat Mintz Methods and systems for annotating biomolecular sequences
WO2011119484A1 (en) * 2010-03-23 2011-09-29 Iogenetics, Llc Bioinformatic processes for determination of peptide binding
WO2012045882A2 (en) * 2010-10-07 2012-04-12 Ac Immune S.A. Pharmaceutical composition
SG11201500938XA (en) * 2012-08-31 2015-04-29 Immunogen Inc Diagnostic assays and kits for detection of folate receptor 1
US9598489B2 (en) * 2012-10-05 2017-03-21 The Trustees Of The Univeristy Of Pennsylvania Human alpha-folate receptor chimeric antigen receptor
GB201507368D0 (en) * 2015-04-30 2015-06-17 Ucl Business Plc Cell
CN107849102B (zh) * 2015-05-15 2022-05-13 希望之城 嵌合抗原受体组合物
CN107523549A (zh) * 2016-06-20 2017-12-29 上海细胞治疗研究院 一种高效稳定表达激活型抗体的car‑t细胞及其用途
CN109536455B (zh) * 2018-12-11 2020-02-21 武汉波睿达生物科技有限公司 一种car-nk细胞及其制备方法和应用

Similar Documents

Publication Publication Date Title
JP2022526420A5 (cg-RX-API-DMAC7.html)
JP2022527173A5 (cg-RX-API-DMAC7.html)
JP2021514664A5 (cg-RX-API-DMAC7.html)
JP2020501531A5 (cg-RX-API-DMAC7.html)
JP6359372B2 (ja) DARPinを含む二重特異キメラ蛋白質
JP2020528750A5 (cg-RX-API-DMAC7.html)
IL276830B1 (en) Anti-claudin 18.2 antibodies and their uses
US7498142B2 (en) Methods of identifying combinations of antibodies with an improved anti-tumor activity and compositions and methods using the antibodies
JP2021528047A5 (cg-RX-API-DMAC7.html)
RU2014101669A (ru) Агенты, связывающие белки r-спондины (rspo), и способы их применения
JP2022526764A5 (cg-RX-API-DMAC7.html)
JP2024531409A5 (cg-RX-API-DMAC7.html)
JP2020529863A (ja) 抗ror1抗体とその作製及び使用方法
JP2024075737A5 (cg-RX-API-DMAC7.html)
JP2017186337A5 (cg-RX-API-DMAC7.html)
JP2014531217A (ja) c−MetのSEMAドメイン内のエピトープに特異的に結合する抗体
IL310938A (en) Anti-CCR8 antibodies and their uses
HRP20150256T1 (hr) Djelatna sredstva za vezanje notch1-receptora i postupci njihove uporabe
JP2009545325A5 (cg-RX-API-DMAC7.html)
JP2013502913A5 (cg-RX-API-DMAC7.html)
JP2013527761A5 (cg-RX-API-DMAC7.html)
CN102209730A (zh) 抗cxcr4抗体及其用于治疗癌症的用途
CN111278861A (zh) Pd-l1抗体、其抗原结合片段及医药用途
TW200918556A (en) Treatment of tumors using specific anti-L1 antibody
JP2022538475A5 (cg-RX-API-DMAC7.html)